The U.S. health regulator on Friday
approved Regeneron Pharmaceuticals drug to treat a
rare blood disease, the company said. The drug, Veopoz, is the first treatment to be approved.
(Reuters) - The U.S. health regulator on Friday approved Regeneron Pharmaceuticals' drug to treat a rare blood disease, the company said. The drug, Veopoz, is the first treatment to be approved by the U.S. Food and Drug Administration (FDA) for pat.
(Reuters) - The U.S. health regulator on Friday approved Regeneron Pharmaceuticals' drug to treat a rare blood disease, the company said. The drug, Ve.
Sandoz to file for approval of aflibercept biosimilar europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.